D-0293-2026 Class II Ongoing
FDA drug recall D-0293-2026 was initiated by Graviti Pharmaceuticals Private Limited on Jan 10, 2026 and is designated Class II. Reason for recall: Presence of Foreign Substance The recall status is ongoing. Affected quantity: 4212 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 28, 2026
- Initiation Date
- Jan 10, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4212 bottles
Product description
Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.
Reason for recall
Presence of Foreign Substance
Distribution pattern
U.S. Nationwide
Code information
Lot# FUB125042G; Exp. 05/13/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0293-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026